Patents by Inventor Sehwan Yang
Sehwan Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11962096Abstract: An electronic device is provided. The electronic device includes a housing, a first antenna and a second antenna which are disposed near at least one edge of the housing inside the housing and a first distance away from each other, wherein the first antenna and second antenna are positioned different distances away from an edge vertical to the one edge, a communication circuit operatively connected to the first antenna and second antenna, at least one sensor, a processor, and a memory.Type: GrantFiled: April 22, 2022Date of Patent: April 16, 2024Assignee: Samsung Electronics Co., Ltd.Inventors: Sehwan Choi, Sukgi Hong, Moonseok Kang, Hyunchul Kim, Yi Yang, Jungsik Park, Sungjun Lim, Jonghoon Jang
-
Publication number: 20220305086Abstract: A method for increasing a lymphocyte count in a subject in need thereof including administering to the subject (i) a modified interleukin-7 of the following formula (I): A?IL-7 wherein A is an oligopeptide consisting of 1 to 10 amino acid residues, and the IL-7 is a polypeptide which is capable of binding to IL-7 receptor; or (ii) an interleukin-7 fusion protein comprising (a) the modified interleukin-7, (b) a second domain containing an oligopeptide having 1 to 10 amino acid residues consisting of methionine, glycine, or a combination thereof; and (c) a third domain which prolongs the half-life of the interleukin-7 fusion protein.Type: ApplicationFiled: September 4, 2020Publication date: September 29, 2022Applicants: GENEXINE, INC., NEOIMMUNE TECH, INC.Inventors: Young Chul SUNG, Jung Won WOO, MinK yu HEO, Sang In YANG, SeHwan YANG
-
Patent number: 8586048Abstract: Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules.Type: GrantFiled: June 11, 2012Date of Patent: November 19, 2013Assignees: Genexine, Inc., Postech Academy-Industry FoundationInventors: Sehwan Yang, Young Chul Sung
-
Patent number: 8586531Abstract: Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules.Type: GrantFiled: June 11, 2012Date of Patent: November 19, 2013Assignees: Genexine, Inc., Postech Academy-Industry Foundation of Phohang University of Science and Technology (Postech)Inventors: Sehwan Yang, Young Chul Sung
-
Patent number: 8586038Abstract: Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules.Type: GrantFiled: November 19, 2010Date of Patent: November 19, 2013Assignees: Genexine, Inc., Postech Academy-Industry Foundation of Phohang University of Science and Technology (Postech)Inventors: Sehwan Yang, Young Chul Sung
-
Patent number: 8529899Abstract: Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules.Type: GrantFiled: June 11, 2012Date of Patent: September 10, 2013Assignees: Genexine, Inc., Postech Academy-Industry FoundationInventors: Sehwan Yang, Young Chul Sung
-
Publication number: 20120276043Abstract: Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules.Type: ApplicationFiled: June 11, 2012Publication date: November 1, 2012Applicants: POSTECH Academy-Industry Foundation of Pohang University of Science & Technology (POSTECH, Genexine Co., LtdInventors: Sehwan YANG, Young Chul Sung
-
Publication number: 20120276096Abstract: Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules.Type: ApplicationFiled: June 11, 2012Publication date: November 1, 2012Applicants: POSTECH Academy-Industry Foundation of Pohang University of Science and Technology (POSTECH), Genexine Co., LtdInventors: Sehwan YANG, Young Chul Sung
-
Publication number: 20120276097Abstract: Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules.Type: ApplicationFiled: June 11, 2012Publication date: November 1, 2012Applicants: POSTECH Academy-Industry Foundation of Pohang University of Science and Technology (POSTECH), Genexine Co., Ltd.Inventors: Sehwan YANG, Young Chul Sung
-
Publication number: 20110091416Abstract: Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules.Type: ApplicationFiled: November 19, 2010Publication date: April 21, 2011Applicants: Genexine Co., Ltd, POSTECH Academy-Industry Foundation of Pohang University of Science and Technology ( POSTECH)Inventors: Sehwan YANG, Young Chul Sung
-
Patent number: 7867491Abstract: Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules.Type: GrantFiled: May 30, 2008Date of Patent: January 11, 2011Assignees: Genexine Co., Ltd., Postech Academy-Industry Foundation of Pohang University of Science and TechnologyInventors: Sehwan Yang, Young Chul Sung
-
Publication number: 20080300188Abstract: Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules.Type: ApplicationFiled: May 30, 2008Publication date: December 4, 2008Applicants: Genexine Co., Ltd, POSTECH Academy-Industry Foundation of PohangInventors: Sehwan Yang, Young Chul Sung